CAPTRUST FINANCIAL ADVISORS

Position in SGMOQ — Sangamo Therapeutics, Inc

CIK 1512024 RALEIGH, NC

Position in SGMOQ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$67,188

+$54,901 QoQ

Shares Held

268,755

+818.7% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	36,464	$22,736,762
2	RPRX	Royalty Pharma plc	337,298	$18,912,298
3	VRTX	Vertex Pharmaceuticals Inc / Ma	35,471	$17,619,509
4	EXEL	Exelixis, Inc.	303,042	$16,488,515
5	LGND	Ligand Pharmaceuticals Inc	34,607	$10,938,926
6	HALO	Halozyme Therapeutics, Inc.	125,946	$9,857,793
7	CELC	Celcuity Inc.	71,445	$7,474,575
8	INCY	Incyte Corp	50,301	$5,702,121

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$67,188	268,755	+818.7%	Shares	Sole	2026-05-15
2025-12-31	$12,287	29,255	0.0%	Shares	Sole	2026-02-17
2025-09-30	$19,600	29,255	0.0%	Shares	Sole	2025-11-19
2025-06-30	$15,797	29,255	0.0%	Shares	Sole	2025-08-15
2025-03-31	$19,308	29,255	0.0%	Shares	Sole	2025-05-15
2024-12-31	$29,840	29,255	+2263.1%	Shares	Sole	2025-02-14
2022-06-30	$5,125	1,238	-35.9%	Shares	Sole	2022-08-23
2022-03-31	$11,219	1,931	-3.8%	Shares	Sole	2022-05-16
2021-12-31	$15,060	2,008	+13.5%	Shares	Sole	2022-02-14
2021-09-30	$15,938	1,769	0.0%	Shares	Sole	2021-11-16
2021-06-30	$21,174	1,769	-63.9%	Shares	Sole	2021-08-16
2021-03-31	$61,397	4,900	+31.5%	Shares	Sole	2021-05-17
2020-12-31	$58,178	3,727	-25.1%	Shares	Sole	2021-02-16
2020-09-30	$47,051	4,979	+2.6%	Shares	Sole	2020-11-17
2020-06-30	$43,464	4,851	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.